Stay updated with breaking news from Commodore Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Rating) – Investment analysts at Lifesci Capital issued their Q1 2023 earnings estimates for Akero Therapeutics in a research note issued to investors on Tuesday, April 11th. Lifesci Capital analyst P. Dolezal expects that the company will post earnings of ($0.58) per share for the quarter. Lifesci Capital has […]
Shares of BELLUS Health Inc. (NASDAQ:BLU – Get Rating) shot up 6.3% on Thursday . The company traded as high as $6.89 and last traded at $6.87. 387,856 shares changed hands during trading, a decline of 41% from the average session volume of 662,235 shares. The stock had previously closed at $6.46. Analyst Upgrades and […]
Gide has advised the financial advisors SVB Securities, LifeSci Capital et Bryan, Garnier & Co in connection with the successful pricing of an oversubscribed Abivax €130 million financing with high-quality U.S. and European biotech specialist investors, by way of a reserved capital increase. This is the largest private placement of a biotech company listed only on Euronext Paris.
EQS-News: ABIVAX / Key word(s): Capital IncreaseAbivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors 22.02.2023 / 18:05 CET/CESTThe issuer is solely responsible for the content of this announcement.NOT FOR DISTRIBUTION IN OR INTO THE...
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR TO U.S. PERSONSAbivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US